Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Study Information
Alliance Study ID: A211102
NCT Study ID (ClinicalTrials.gov): NCT01905046
Alliance Committee: Cancer Control
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Victoria Seewaldt, MD
Status: ACTIVE_NOT_RECRUITING
Study Description
This randomized phase III trial studies metformin hydrochloride to see how well it works compared to placebo in preventing breast cancer in patients with atypical hyperplasia or in situ breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of metformin hydrochloride may prevent breast cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Locations (27)
City of Hope Comprehensive Cancer Center
Duarte, California 91010
United States
Los Angeles County-USC Medical Center
Los Angeles, California 90033
United States
USC / Norris Comprehensive Cancer Center
Los Angeles, California 90033
United States
City of Hope South Pasadena
South Pasadena, California 91030
United States
The Community Hospital
Munster, Indiana 46321
United States
University of Kansas Cancer Center
Kansas City, Kansas 66160
United States
Cotton O’Neil Cancer Center / Stormont Vail Health
Topeka, Kansas 66606
United States
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United States
Roswell Park Cancer Institute
Buffalo, New York 14263
United States
Mount Sinai Hospital
New York, New York 10029
United States
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
New York, New York 10032
United States
Duke University Medical Center
Durham, North Carolina 27710
United States
The Christ Hospital
Cincinnati, Ohio 45219
United States
Ohio State University Comprehensive Cancer Center
Columbus, Ohio 43210
United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104
United States
Prisma Health Cancer Institute – Spartanburg
Boiling Springs, South Carolina 29316
United States
Prisma Health Cancer Institute – Easley
Easley, South Carolina 29640
United States
Greenville Health System Cancer Institute-Andrews
Greenville, South Carolina 29601
United States
Prisma Health Cancer Institute – Butternut
Greenville, South Carolina 29605
United States
Prisma Health Cancer Institute – Faris
Greenville, South Carolina 29605
United States
Prisma Health Greenville Memorial Hospital
Greenville, South Carolina 29605
United States
Prisma Health Cancer Institute – Eastside
Greenville, South Carolina 29615
United States
Prisma Health Cancer Institute – Greer
Greer, South Carolina 29650
United States
Prisma Health Cancer Institute – Seneca
Seneca, South Carolina 29672
United States
M D Anderson Cancer Center
Houston, Texas 77030
United States
Doctor’s Hospital of Laredo
Laredo, Texas 78041
United States
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin 53792
United States
Data Sources & Contacts
Full trial details
For more Information